Conceptrichtlijn colorectaal carcinoom 2013 - Oncoline

8189819081918192819381948195819681978198819982008201820282038204820582068207820882098210821182128213821482158216821782188219822082218222822382248225822682278228822982308231823282338234823582368237823882398240Renehan AG, Egger M, Saunders MP, O'Dwyer ST. Impact on survival of intense follow-up after curativeresection of colorectal cancer: systematic review and meta-analysis of randomized trials. BMJ 2002;324:1-8.Renehan AG, O'Dwyer ST, Whynes DK. Cost effectiveness analysis of intensive versus conventional follow upafter curative resection for colorectal cancer. BMJ 2004;328:81.Reuter NP, Woodall CE, Scoggins CR, McMasters KM, Martin RC. Radiofrequency ablation vs. resection forhepatic colorectal metastasis: therapeutically equivalent? J Gastrointest Surg. 2009 Mar;13(3):486-91.Rex DK, Kahi CJ, Levin B, Smith RA, Bond JH, Brooks D et al. American Cancer Society; US Multi-Society TaskForce on Colorectal Cancer. Guidelines for colonoscopy surveillance after cancer resection: a consensus updateby the American Cancer Society and the US Multi-Society Task Force on Colorectal Cancer. Gastroenterol2006;130:1865-71.Reza MM, Blasco JA, Andradas E, Cantero R, Mayol J. Systematic review of laparoscopic versus open surgeryfor colorectal cancer. Br J Surg. 2006 Jul 17;93(8):921-8.Ribero D, Wang H, Donadon M, Zorzi D, Thomas MB, Eng C, et al. Bevacizumab improves pathologic responseand protects against hepatic injury in patients treated with oxaliplatin-based chemotherapy for colorectal livermetastases. Cancer. 2007 Dec 15;110(12):2761-7.Ricciardi R, Madoff RD, Rothenberger DA, Baxter NN. Population-based analyses of lymph node metastases incolorectal cancer. Clinical Gastroenterology & Hepatology. 2006;4(12):1522-7.Rigby K, Brown SR, Lakin G, Balsitis M, Hosie KB. The use of a proforma improves colorectal cancer pathologyreporting. Ann R Coll Surg Engl 1999;81:401-3.Rivoire M, De Cian F, Meeus P, Negrier S, Sebban H, Kaemmerlen P. Combination of neoadjuvantchemotherapy with cryotherapy and surgical resection for the treatment of unresectable liver metastases fromcolorectal carcinoma.Cancer 2002; 95:2283-2292.Rodel C, Martus P, Papadoupolos T, Fuzesi L, Klimpfinger M, Fietkau R, et al. Prognostic significance of tumorregression after preoperative chemoradiotherapy for rectal cancer. J Clin Oncol 2005;23:8688-96.Rodgers MS, McCall JL. Surgery for colorectal liver metastases with hepatic lymph node involvement: asystematic review.Br J Surg 2000; 87:1142-1155Rodriguez-Moranta F, Salo J, Arcusa A, Boadas J, Pinol V, Bessa X et al. Postoperative surveillance in patientswith colorectal cancer who have undergone curative resection: a prospective, multicenter, randomized, controlledtrial. J Clin Oncol 2006;24(3):386-93.Rohren EM, Paulson EK, Hagge R, et al. The role of F-18 FDG positron emission tomography in preoperativeassessment of the liver in patients being considered for curative resection of hepatic metastases from colorectalcancer.Clin Nucl Med 2002;27:550-555.Rosen M, Chan L, Beart RW Jr, Vukasin P, Anthone G. Follow-up of colorectal cancer: a meta-analysis. DisColon Rectum 1998;41:1116-1126.Rothbarth J, Pijl ME, Vahrmeijer AL, et al. Isolated hepatic perfusion with high-dose melphalan for the treatmentof colorectal metastasis confined to the liver. Br J Surg 2003;90:1391-1397.Richtlijn Colorectaal carcinoom en Colorectale levermetastasen 2013 - CONCEPT 188